A push by House Democrats and President Trump to boost stimulus payments to $2,000 stalls in the Senate; AstraZeneca’s Covid-19 vaccine gets U.K. approval; hedge fund Third Point pushes Intel to make changes.
Source link
This article originally appeared on finance.yahoo.com
